Management of Severe COVID-19 Infection in Children: A Therapeutic Challenge
Itzhak Brook, MD, Editor-in-Chief, International Journal of Clinical Pediatrics

Although coronavirus disease 2019 (COVID-19) occurs in children, compared to adults they have a milder disease. They are infrequently admitted to intensive care units, have better prognosis and their mortality is low. However, because children are often asymptomatic or experience a mild disease the true incidence of COVID-19 in children may be higher. Infected children should be isolated and mild cases should receive supportive treatment at home [2]. The use of antiviral or immunomodulatory therapies should only be considered within a clinical trial setting or on a case-to-case basis. Full Text
(International Journal of Clinical Pediatrics, Vol. 9, No. 4, Dec 2020. p103-104)

Let's Combat COVID-19 Together.
The COVID-19 outbreak presents the unprecedented challenge for world public and medical practitioners and healthcare givers. The Elmer Press Inc is herein to participate the combating COVID-19 through all possible efforts, as a clinical medicine publisher, we would facilitate the rapid and effective communication of management of this pandemic, we will consider submissions related to all aspects of this disease, including prevention, basic viral research, epidemiology, treatment, vaccine, fast screening, diagnosis, prognosis, etc. We will process such manuscripts in priority and publish them ASAP after peer-reviewed and accepted.  For more information, please contact production@elmerpress.com or the individual journal's editor.